Friday,DECember 10, 2021
Neuromodulation in the management of heart failure and its comorbidities: diabetes, sleep apnea and hypertension
08:00 - 09:40 | Ballroom
Moderators: Howard Levin, Horst Sievert
Panelists: Marat Fudim, Jozef Bartunek, Philipp Lurz
Translational concepts in the development of new treatment strategies >> Kalyanam Shivkumar
Renal denervation for heart failure treatment: Renal denervation for HFpEF: trial design considerations - how can RDN learn from trials of inter-atrial shunt trials and SGLT-2 inhibitors >> Philipp Lurz
Renal denervation for heart failure treatment: Renal denervation for HFrEF: how to design trials given all the other treatments available - where would RDN fit in this crowded space? >> Felix Mahfoud
Treatment of central sleep apnea in heart failure patients: Remede >> Marat Fudim
Stent-based barostimulation: Results of the first in man trial >> Horst Sievert
An endovascular approach for treating HF patients using an implantable active Neuromodulation Implant >> Jozef Bartunek
Metavention: Renal and hepatic artery denervation to treat metabolic syndrome >> Horst Sievert
Pathogenesis and treatment of heart failure with preserved ejection fraction (HFpEF)
10:10 - 11:00 | Ballroom
Moderator: Daniel Burkhoff, Gianluigi Savarese
Panelists: Piotr Ponikowski, Jozef Bartunek, Philipp Lurz
Q&A Facilitator: Gry Dahle
What are the underlying causes of HFpEF >> Rolf Wachter
The many faces of HFpEF – not just one disease >> Gianluigi Savarese
The failures, the learnings and the encouraging future - overview of potential therapies for HFpEF (medical therapy, clinical trial design, devices) >> Piotr Ponikowski
What is the causal role for Tricuspid Regurgitation in HFpEF? >> Yan Topilsky
The splanchnic bed is a novel target in patients with heart failure with preserved ejection fraction (HFpEF) s
11:00 - 12:15 | Ballroom
Moderator: Howard Levin
Panelists: Marat Fudim, Piotr Ponikowski, Daniel Burkhoff
Overview of the physiology of the splanchnic bed in HFpEF and HFrEF >> Marat Fudim
Long-term follow-up on FIH endovascular therapy using the Satera Ablation System in HFpEF and HFrEF >> Sanjiv Shah
Current status of the REBALANCE-HF US FDA randomized feasibility clinical trial in HFpEF >> Sanjiv Shah
Where does this therapy potentially fit into current landscape of treatments for HFpEF and HFrEF >> Piotr Ponikowski
Telemedicine
12:30 - 14:00 | Ballroom
Moderator: William Abraham, Stefan Anker
Panelists: Marat Fudim, David Kuraguntla, Jozef Bartunek
Q&A Facilitator: Martin Swaans
Telemedicine advancements during the COVID-19 pandemic: What's worked, what hasn't, and what's to come? >> Marat Fudim
Non-invasive assessment of lung fluid content >> Stefan Anker
Implantable Hemodynamic Monitors: CardioMEMS >> Philip Adamson
Implantable Hemodynamic Monitors: The first in heart microcomputer for the management of HF patients >> William Abraham
Implantable Hemodynamic Monitors: Exercise stress testing in remote heart failure management >> Jozef Bartunek
Non-invasive assessment of fluid status and arrthymogenic >> David Kuraguntla
Non-invasive cardiac filling pressure compared with PCWP >> Yuhui Zhang
Durable mechanical circulatory support
14:00 - 15:10 | Ballroom
Moderators: Navin Kapur, Daniel Burkhoff
Panelists: Gry Dahle, Petrus Jansen, Issam Moussa
Q&A Facilitator: Corstiaan den Uil
CorWave LVAD - a biomimetic pump for physiologic pulsatility >> Trevor Snyder
HeartMate 3 >> Robert Kormos
Carmat Aeson TAH >> Petrus Jansen
Evaheart >> Oliver Voigt
Impella 5.5 >> Bobbi Bogaev Chapman
Impella BRT >> Sonya Bhavsar
Acute mechanical circulatory support
15:40 - 17:10 | Ballroom
Moderators: Navin Kapur, Daniel Burkhoff
Panelists: Ralph D'Ambrosio, Rajan Patel, Jace Heuring, Corstian den Uil, Martin Swaans
Q&A Facilitator: Gry Dahle
Acute MCS state of the art >> Jacob Moeller
ECP EFS >> Amir Kaki
ProtekDuo in COVID ARDS >> Amir Kaki
Aortix EFS >> Jace Heuring
SecondHeart >> Leslie Miller
PreCardia EFS >> Navin Kapur
PreCardia clinical trial >> Michael Kiernan
New Impella RP >> Christoph Nix
IABP >> Corstiaan den Uil
Insights from the PULSE Trial & iVAC 2L in MCS facilitated high-risk PCI >> Nicolas Van Mieghem
New and upcoming concepts and devices
17:10 - 18:00 | Ballroom
Moderators: Navin Kapur, Daniel Burkhoff
Panelists: Ulrich Jorde, Yuval Binur, Sitaramesh Emani, Lee Goldberg
Q&A Faculitator: Horst Sievert
Synchronized diaphragmatic stimulation for the treatment of symptomatic heart failure >> Lee Goldberg
Importance of mitral valve plane movement in heart pumping - updated insights >> Ellen Ostenfeld
Syntach - a novel minimally invasive cardiac support system >> Kristian Solem
Doraya >> Ulrich Jorde
Targeting enhanced decongestion while aiming to preserve renal function – lymphatic-powered interstitial decongestion >> Sitaramesh Emani
Percutaneous Pericardial Resection >> Barry A. Borlaug
Device Development Workshop
18:00 - 19:00 | Ballroom
Moderator: Kathleen A. Marshall
Panelists: Yuval Binur, Florian Ludwig, Wolfgang Goetz
Cocktails, Covid and Recovery: How Innovators Adapt
Join a pre-cocktail fireside chat in which we talk about recovery and how things have adapted to a new environment and how some of what we have encountered has created opportunities for permanent change for the better, e.g. remote documentation, telehealth follow-up visits, digitalization of clinical data collection methods and links between actors. We will discuss real-world examples of inventive compliance and talk about how adapting to change in medicine is likely to generate better patient outcomes—all with the idea that innovation is about adaptation.
Saturday, DECember 11, 2021
E-poster presentation
07:00 - 08:00 | Exhibition area
Electrotherapy for heart failure treatment
08:00 - 08:35 | Ballroom
Moderators: Hendrik Bonnemeier, Horst Sievert
Panelists: Issam Moussa, Ralph Stephan von Bardeleben, Gry Dahle
Q&A Facilitator: Martin Bergmann
New trial results: More patients may benefit from CRT therapy! >> Christian Butter
CCM – Closing the gap: When OMT is not enough >> Hendrik Bonnemeier
Atrial fibrillation in heart failure >> Christian Ukena
Interventions for LV Reconstruction and support
08:35 - 09:35 | Ballroom
Moderators: Horst Sievert, Daniel Burkhoff
Panelists: Ralph Stephan von Bardeleben, Ulrich Jorde, Martin Swaans
Q&A Facilitator: Issam Moussa
Therapeutic opportunity & single center experience >> Patrick Klein
Predictors of Revivent LV restoration outcomes >> Rishi Puri
The AccuCinch Ventricular Restoration System >> Ulrich Jorde
V-sling: A left ventricular transcatheter repair device for HFrEF >> Horst Sievert
Transcatheter intramyocardial hydrogel injection (XDrop): FIM results >> Ling Tao
Percutaneous radiofrequency ablation of HOCM >> Liwen Liu
Right heart failure
09:35 - 10:45 | Ballroom
Moderators: Ralph Stephan von Bardeleben, Gry Dahle
Panelists: Markus Ferrari, Daniel Burkhoff, Martin Swaans
Q&A Facilitator: Kolja Sievert
Pathology and pathophysiology, clinical relevance of RHF-does it help to treat TR? >> Gry Dahle
Evaluation of right ventricular function and its importance in RHF >> Martin Swaans
Right heart failure in the guidelines >> Gry Dahle
Mechanical assist in RHF using the PERKAT RV pulsatile right ventricular support device >> Markus Ferrari
PHT in RHF, monitoring and treatment >> Tobias Ruf
Tricuspid trial for RHF: Haemodynamic perspective >> Daniel Burkhoff
Valve interventions in patients with heart failure
11:15 - 12:50 | Ballroom
Moderators: Nicolas Van Mieghem, Hueseyin Ince
Panelists: Issam Moussa, Philip Raake, Gry Dahle, Markus Ferrari, Martin Swaans, Daniel Kretzschmar
Q&A Facilitator: Tobias Ruf
Introduction >> Hueseyin Ince
Recent innovations for the management of patients with valvular heart disease – focus on heart failure >> Eberhard Grube
2021 European guidelines on heart failure – focus on heart valves >> Marco Metra
Echo criteria to identify TEER responders beyond COAPT >> Martin Swaans
Volume outcome relation in percutaneous FMR treatment >> Alper Öner
Role of the right sided heart in FMR >> Jeroen J Bax
The impact of tricuspid regurgitation on patient outcomes >> David Messika-Zeitoun
What do the guidelines say about tricuspid regurgitation? >> Marco Metra
Status on transcatheter tricuspid valve interventions – when & how >> Philip Raake
The current evidence and the vast clinical study & registry pipeline >> Jörg Hausleiter
Case presentation: improving patient outcomes and QoL with a new device (PASCAL Ace) >> Leonhard Schneider
Prevalence, prognosis, and management of exercise-induced severe MR in patients with heart failure >> Issam Moussa
Closing remarks >> Nicolas Van Mieghem
Interatrial shunts
13:35 - 15:30 | Ballroom
Moderators: William Abraham, Daniel Burkhoff, Horst Sievert
Panelists: Martin Bergmann, Dietmar Schranz, Ralph Stephan von Bardeleben
Q&A Facilitator: Martin Swaans
The physiological rationale for IASD as a treatment for heart failure >> Daniel Burkhoff
Lessons learned and being learned from the Corvia Reduce LAP-2 Study >> Sanjiv Shah
IASD across the spectrum of EFs: The V-Wave experience >> Michaela Hell
Are different size shunts required? The AFR experience >> Martin Bergmann
Alternate means for creating a durable shunt without leaving a device behind: The Alleviant experience >> Lars Lund
Alternate means of creating a durable shunt without leaving a device behind: The Noya experience >> Chaim S. Lotan
Alternate means of creating a durable shunt without leaving a device behind: The InterShunt experience >> Horst Sievert
Interatrial shunting for pulmonary hypertension >> William Abraham
Clinical trial considerations for IASD pivotal studies >> Gregg W. Stone
Interatrial shunt for end-stage amyloid heart disease (recorded case) >> Horst Sievert
The future of device-based therapies and diagnostics for heart failure
16:00 - 16:30 | Ballroom
Moderators: Howard Levin
Panelists: Issam Moussa, Martin Swaans, Yuval Binur
Q&A Facilitator: Marat Fudim
Cardiovascular innovations in Corona time >> Yuval Binur
We now have a drug therapy which is effective in HFpEF: Do we still need a device based therapy >> Deepak Bhatt
I am confused! Out of these 50+ treatment options – when to use what?
16:30 - 18:00 | Ballroom
Moderators: Martin Bergmann, Horst Sievert
Panelists: Issam Mousa, Lee Goldberg, Daniel Burkhoff
Q&A Facilitator: Gry Dahle
Case 1 >> Kolja Sievert
Case 2 >> Judith Steffan
Case 3 >> Natalia Galeru